Associated Papers
Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis.
Yan Y et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association, 2022
Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction.
Pandey CP et al.
The Indian Journal of Medical Research, 2019
Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (‑806 C>T) alleles among an Iranian population of different ethnicities.
Dehbozorgi M et al.
Molecular Medicine Reports, 2018
The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children.
Seven M et al.
Molecular Diagnosis & Therapy, 2014
Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency.
Linder MW et al.
Clinical Chemistry, 1997
Select a paper to view details